This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Implied Volatility Surging for Kindred Healthcare (KND) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Kindred Healthcare (KND) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Kindred Healthcare, Inc. (KND) Stock?
by Zacks Equity Research
Surging level of implied volatility makes Kindred Healthcare, Inc. (KND) stock lucrative to the option traders.
Is Kindred Healthcare (KND) a Good Stock for Value Investors?
by Zacks Equity Research
Kindred Healthcare (KND) appears to be a good choice for value investors right now, given its favorable P/E and P/S metrics.
Ventas (VTR) to Gain from Life Science Assets and SNF Sale
by Zacks Equity Research
Ventas' (VTR) life-science real estate investments and lowering of skilled nursing facilities' exposure augur well for growth, but rising supply of senior housing assets remains a concern.
Ventas Sells 22 Kindred-Operated SNFs Out of 36 in Phase I
by Zacks Equity Research
Ventas (VTR) will be able to bring down its NOI from skilled nursing facilities to just 1% of its aggregate NOI, following the anticipated sale of the total 36 Kindred operated facilities.
Ventas' (VTR) Life Science Asset Investments to Stoke Growth
by Zacks Equity Research
Ventas (VTR) is making investment for future prospects through selective development and redevelopment. This would include new ground-up medical office and life science developments.
New Strong Sell Stocks for July 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Ventas (VTR) Reiterates Sale of 36 Kindred Operated SNFs
by Zacks Equity Research
Ventas Inc. (VTR) has reaffirmed the expected sale of 36 skilled nursing facilities (SNFs), for $700 million, which are currently being operated by Kindred Healthcare.
Do Options Traders Know Something About Kindred Healthcare (KND) Stock We Don't?
by Zacks Equity Research
Investors in Kindred Healthcare, Inc. (KND) need to pay close attention to the stock based on moves in the options market lately.
Can the Value Investors Consider Kindred (KND) As a Great Pick?
by Zacks Equity Research
Value Investors may Consider Kindred (KND) As a Great Pick on the back of its solid key value statistics.